Recerca

Àrea 5

Trasplantament de progenitors hemopoètics

Articles de l'any 2010
Original

Originals publicats: 12

Factor d'impacte: mitjana: 3.64, total: 43.66

  • Regeneration of insulin production by autologous bone marrow blood autotransplantation in patients with type 1 diabetes

    Esmatjes E, Montana X, Real MI, Blanco J, Conget I, Casamitjana R, Rovira M, Gomis R, Marin P
    DIABETOLOGIA. 2010; 53: 786-789. IF: 6.551

  • Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

    Cordonnier C, Rovira M, Maertens J, Olavarria E, Faucher C, Bilger K, Pigneux A, Cornely OA, Ullmann AJ, Bofarull RM, DeLaCamara R, Weisser M, Liakopoulou E, Abecasis M, Heussel CP, Pineau M, Ljungman P, Einsele H
    HAEMATOL-HEMATOL J. 2010; 95: 1762-1768. IF: 6.416

  • Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation

    DeLarrea CF, Martinez C, Gaya A, Lopez-Guillermo A, Rovira M, Fernandez-Aviles F, Lozano M, Bosch F, Esteve J, Nomdedeu B, Montserrat E, Carreras E
    ANN ONCOL. 2010; 21: 1211-1216. IF: 5.647

  • Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort

    Escurriol V, Cofan M, Moreno-Iribas C, Larranaga N, Martinez C, Navarro C, Rodriguez L, Gonzalez CA, Corella D, Ros E
    J LIPID RES. 2010; 51: 618-624. IF: 4.917

  • Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft Source

    Ferra C, Sanz J, DeLaCamara R, Sanz G, Bermudez A, Valcarcel D, Rovira M, Serrano D, Caballero D, Espigado I, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, Garcia-Noblejas A, Diez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM
    BIOL BLOOD MARROW TR. 2010; 16: 957-966. IF: 3.149

Revisió

Revisions publicades: 4

Factor d'impacte: mitjana: 3.92, total: 15.66

  • Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome

    Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, Guinan E, Vogelsang G, Krishnan A, Giralt S, Revta C, Carreau NA, Iacobelli M, Carreras E, Ruutu T, Barbui T, Antin JH, Niederwieser D
    BIOL BLOOD MARROW TR. 2010; 16: 157-168. IF: 3.149

  • Hematopoietic stem cell transplantation for multiple myeloma beyond 2010

    Blade J, Rosinol L, Cibeira MT, Rovira M, Carreras E
    BLOOD . 2010; 115: 3655-3663. IF: 10.555

Multicèntrics

Multicèntrics publicats: 1

Factor d'impacte: mitjana: 10.56, total: 10.56

  • Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34(+) cells from leukapheresis products autografted during the first remission

    Gorin NC, Labopin M, Reiffers J, Milpied N, Blaise D, Witz F, DeWitte T, Meloni G, Attal M, Bernal T, Rocha V
    BLOOD. 2010; 116: 3157-3162. IF: 10.555

Més articles